|
Dr. Poste is the Director of The Biodesign Institute at Arizona State University. In addition to his academic post he serves as Chief Executive of a consulting company, Health Technology Networks, that specializes in the application of genomic technologies and computing in healthcare. He is Chairman of Orchid Biosciences, the leading company in DNA forensic analysis, and serves on the Board of Directors of Monsanto and Exelixis. From 1992 to 1999 he was Chief Science and Technology Officer and President, R&D of SmithKline Beecham (SB). During his tenure at SB he was associated with the successful registration of 31 drug, vaccine and diagnostic products. In 2004 he was named as "R&D Scientist of the Year" by R&D Magazine. He is a Fellow of the Royal Society, and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University and a member of the Council for Foreign Relations. He is a member of the Defense Science Board of the US Department of Defense. He also serves as a member of the National Academy Sciences Working Group on Biological Weapons, the Forum on Microbial Threats of the Institute of Medicine Board on Global Health and the Institute of Medicine Committee on Advances in Technology and New Generation Biowarfare Threats. | 